Source: International Congress 2014 – New and old players in fibrotic lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
L. Hinkofer, D. Jenne (München, Germany). An animal model for granulomatosis with polyangiitis. Eur Respir J 2014; 44: Suppl. 58, 3918

Member's Comments

No comment yet.

Related content which might interest you: Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases Source: International Congress 2014 – ILDs 6 Year: 2014 Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome Source: International Congress 2014 – ILDs 1 Year: 2014 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Essential oils reduced lung inflammation in a model of acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum Source: International Congress 2014 – ILDs 2 Year: 2014 An atypical presentation of granulomatosis with polyangiitis (GPA) with pituitary involvement Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Lung inflammation was attenuated by sakuranetin treatment in a model of acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Atypical variants of clinical course of sarcoidosis Source: International Congress 2014 – ILDs 6 Year: 2014 Increased Severity of Asthma in Atopic Patients with Eosinophilic Granulomatosis with Polyangiitis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Pathogenic potential of an autoprocessed form of neutrophil elastase Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Inhibited IL-17A ameliorates sarcoid-like granulomatosis in mice Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007 Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Cognitive failure in sarcoidosis Source: International Congress 2014 – Sarcoidosis Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014